Navigation Links
Alexza Reports 2011 Third Quarter Financial Results and Provides Business Update
Date:11/7/2011

2; (Staccato® Loxapine) New Drug Application (NDA) as a complete, class 2 response to the FDA's Complete Response Letter, and indicated a Prescription Drug User Fee Act (PDUFA) goal date of February 4, 2012.
  • On October 5, 2011, Alexza entered into a commercial partnership for ADASUVE with Grupo Ferrer Internacional, S.A. (Grupo Ferrer) for the commercialization of ADASUVE in Europe, Latin America, Russia and the Commonwealth of Independent States countries.
  • On October 24, 2011, Alexza announced that the FDA has scheduled a meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) for December 12, 2011, at which the ADASUVE NDA will be discussed.
  • On October 26, 2011, Alexza filed a Marketing Authorization Application (MAA) for ADASUVE with the European Medicines Agency (EMA).

  • Alexza believes that, based on its cash, cash equivalents and marketable securities balance at September 30, 2011, the proceeds from the Grupo Ferrer partnership, net of the $5 million payment to the former Symphony Allegro stockholders, and the Company's current expected cash usage, it has sufficient capital resources to meet its anticipated cash needs, at its current expense levels, into the second quarter of 2012.  Changing circumstances may cause Alexza to consume capital significantly faster or slower than currently anticipated, or to alter its operations.

    Financial Results - Periods Ended September 30, 2011 and 2010

    Alexza recorded $1.3 million and $3.8 million of revenues in the three and nine months ended September 30, 2011, respectively, compared to $0.7 million in both the three and nine months ended September 30, 2010.  The revenues were related to the license agreement with Cypress Biosciences, Inc., signed in the third quarter of 2010.

    GAAP operating expenses were $11.2 million and $29.6 million in the three and nine-month periods ended September 30, 2011, respectively, compared to operating expenses o
    '/>"/>

    SOURCE Alexza Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Alexza Pharmaceuticals to Present at the Lazard Capital Markets 8th Annual Healthcare Conference
    2. Alexza to Announce 2011 Third Quarter Financial Results on Monday, November 7, 2011
    3. Alexza Announces the Adasuve™ (Staccato® Loxapine) PDAC Meeting Date of December 12, 2011
    4. Alexza Pharmaceuticals to Present at the 18th Annual NewsMakers in the Biotech Industry Conference
    5. Alexza and Grupo Ferrer Establish Partnership for the Commercialization of Adasuve™ (Staccato® Loxapine) in Europe and Latin America
    6. Alexza Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
    7. Alexza Announces Adasuve™ (Staccato® Loxapine) PDUFA Goal Date of February 4, 2012
    8. Alexza Announces Resubmission of AZ-004 (Staccato® Loxapine) NDA
    9. Alexza to Announce 2011 Second Quarter Financial Results on Monday, August 8, 2011
    10. Alexza Reports 2011 First Quarter Financial Results and Provides Business Update
    11. Alexza to Present at the MDB Bright Lights Conference 2011
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/30/2014)... 30, 2014 Arbor Pharmaceuticals, LLC. - ... Global Markets Direct,s, ,Arbor Pharmaceuticals, LLC. - Product ... the Arbor Pharmaceuticals, LLC.,s pharmaceutical research and development ... the current therapeutic developmental pipeline of Arbor Pharmaceuticals, ... therapeutics assessment by drug target, mechanism of action ...
    (Date:9/30/2014)... BURLINGTON, Mass. , Sept. 30, 2014  Decision ... (PV) devices in Brazil , ... and China (BRIC) will see ... techniques are increasingly favored over surgical procedures. Although revenues ... care resources, reimbursement challenges, prolonged device approval times and ...
    (Date:9/30/2014)... , Sept. 30, 2014  According to their ... of cancer clinical trials is going through a ... and the work of the current clinical trial ... of ,next generation, clinical trials, which will ultimately ... The company has been recognized by ...
    Breaking Medicine Technology:Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2014 2Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2014 3Brazilian, Russian, Indian and Chinese Markets for Peripheral Vascular Devices Will See Strong Expansion Through 2023 2Brazilian, Russian, Indian and Chinese Markets for Peripheral Vascular Devices Will See Strong Expansion Through 2023 3Small Denver Company Pharmatech driving a large revolution in how cancer clinical trials are managed 2
    ... , April 27, 2010 Shire plc (LSE: ... it has received a Paragraph IV Notice Letter from Anchen,Pharmaceuticals, ... Application ("ANDA") for a generic version of Shire,s 1 mg, ... tablets, INTUNIV(TM).,Shire had previously reported in March 2010 ...
    ... April 27 For a second consecutive year, following the ... Auto Thefts) is cautioning Michigan drivers, and now auto dealers ... theft-related crimes.   , , ... increased vehicle security features, and the continuing success of Michigan ...
    Cached Medicine Technology:Shire Receives INTUNIV(TM) Paragraph IV Notice Letter From Anchen 2Shire Receives INTUNIV(TM) Paragraph IV Notice Letter From Anchen 3H.E.A.T. Warns Drivers, Auto Dealers of Continuing Trend in Unconventional Auto Crimes 2H.E.A.T. Warns Drivers, Auto Dealers of Continuing Trend in Unconventional Auto Crimes 3
    (Date:10/1/2014)... study published today in the Journal of the ... than 50 years with moderate or severe chronic knee ... from the University of Melbourne randomly assigned 282 patients ... no acupuncture or sham or pretend laser treatment. ... and acupuncturists blinded to laser and sham (inactive) laser ...
    (Date:10/1/2014)... 1, 2014) Despite a policy focus on ... disabilities, this vulnerable population continues to have significant ... The Journal of the American Dental Association , ... Tufts University School of Dental Medicine report on ... at-home oral care provided by caregivers to adults ...
    (Date:10/1/2014)... Insuranceragents.info has released a new blog post explaining how ... family members. , Life insurance plans provide important financial ... should always carry a life insurance policy as their ... the family. , Clients can choose from several ... coverage or from a permanent policy. No medical exam ...
    (Date:10/1/2014)... Phoseon Technology, the pioneer in developing ... business worldwide. This rapid growth includes increased hiring for ... efforts. The company has experienced average annual growth rates ... this growth to continue in the future as new ... , “We are very pleased that UV ...
    (Date:10/1/2014)... new genetic finding from Duke Medicine suggests that some ... might also be hard-wired to gain weight when exposed ... , An estimated 13 percent of people, all of ... knowing this could help them reduce heart disease with ... stress management. , "Genetic susceptibility, psychosocial stress and metabolic ...
    Breaking Medicine News(10 mins):Health News:Study finds acupuncture does not improve chronic knee pain 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 3Health News:Life Insurance for Families - Clients Can Compare Affordable Rates Online! 2Health News:Phoseon Technology Continues to Drive Growth Worldwide 2Health News:Gene interacts with stress and leads to heart disease in some people 2
    ... The following is being,issued by Center for Consumer Freedom:, ... preparing,to celebrate time-honored traditions like caroling, tree-trimming, and,leaving cookies ... of trans fat,bans and frivolous lawsuits, serving baked goods ... the receiving end of a very un-merry obesity lawsuit., ...
    ... Strategic ... Plan, CLEVELAND, Dec. 20 ... Executive Officer,University Hospitals, has agreed to serve as the health system,s leader for,an ... Board of Directors, said, "I join my,Board colleagues in underscoring our support for ...
    ... Need, NORTH KINGSTOWN, R.I., Dec. 20 On ... of Dominion Diagnostics,joined together in the spirit of the ... RI. The party proved a sight to be seen; ... Ballroom, and,many guests dressed to the nines for the ...
    ... PICK ONE" ENCOURAGING ... TOGETHER, NEW YORK, Dec. 20 Just in time ... launch of "Kick One, Pick One",(KOPO), the network,s new pro-social ... more time together. Bowing Jan. 1, KOPO is an,on-air, online ...
    ... groundbreaking experiment published in Cloning & Stem Cells, scientists ... embryonic stem cell lines that open the door for ... an immune reaction in large segments of the population. ... have a simple genetic profile in the critical areas ...
    ... Vegas business and Oak Ridge National Laboratory are improving the ... heart failure. , The task for ORNL researchers Chuck Britton, ... Noninvasive Medical Technologies ZOE, a medical device that monitors a ... importance to members of the military and to thousands of ...
    Cached Medicine News:Health News:Center for Consumer Freedom Releases 'Don't Sue Me Santa' Christmas Cookie Liability Waiver 2Health News:University Hospitals Chief Executive Officer Extends Contract 2Health News:University Hospitals Chief Executive Officer Extends Contract 3Health News:Dominion Diagnostics Supports Rhode Island's Toys for Tots Initiative at Its 2007 Holiday Celebration 2Health News:Nick at Nite Asks Families to Kick a Bad Habit, Pick a Good One in 2008 2Health News:Nick at Nite Asks Families to Kick a Bad Habit, Pick a Good One in 2008 3Health News:Human embryonic stem cell lines created that avoid immune rejection 2Health News:Nevada company, ORNL develop potential lifesaver 2
    Archimedes is an innovative specialty calculator. Forget having to remember complicated formulas, just enter the values and out come the results....
    A handy, quick reference for physicians, nurses, and other health care providers treating cancer patients....
    A handy quick-reference tool for busy residents and clinicians with key facts and points essential for day-to-day patient care....
    Provides reliable information on the most commonly prescribed drugs, their side effects, interactions and cost of therapy....
    Medicine Products: